Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 72 Show results per page	View Search Criteria \| Help With Results

Last Modified: 2/26/2008


1.		Phase II/III Randomized Study of EM/VBL vs EM for Metastatic Hormone-Refractory Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				any age								EORTC-30944

Last Modified: 6/1/1996


2.		Phase III Randomized Study of VBL vs VBL/EM for Metastatic Hormone-Refractory Prostate Cancer (Summary Last Modified 06/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				Other				HOG-GU93-1 NCI-V94-0424

Last Modified: 1/28/2004


3.		Phase III Study of Chemo/Hormonal Therapy vs Androgen Ablation Alone as Initial Therapy in Patients With Unresectable/Metastatic Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				MDA-DM-95231 NCI-G96-1044, NCT00002855

Last Modified: 1/1/1999 First Published: 2/1/1998


4.		Phase III Study of Adjuvant Estramustine and Etoposide vs Observation Following Radical Prostatectomy for Stage II, III, or IV Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18-70				NCI				CWRU-1894 NCI-G97-1360

Last Modified: 1/12/2009 First Published: 9/1/1999


5.		Phase III Randomized Study of Docetaxel and Estramustine Versus Mitoxantrone and Prednisone in Patients With Hormone-Refractory, Metastatic Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				SWOG-S9916 CLB-99808, NCCTG-S9916, NCT00004001, S9916

Last Modified: 11/10/2008 First Published: 11/1/1999


6.		Phase III Randomized Study of Androgen Suppression and Radiotherapy With or Without Subsequent Paclitaxel, Estramustine, and Etoposide in Patients With Localized High-Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Over 18				NCI				RTOG-9902 RTOG-DEV-1020, RTOG-99-02, NCT00004054

Last Modified: 1/25/2008 First Published: 12/1/2001


7.		Phase III Randomized Study of Second-Line Hormonal Therapy (Ketoconazole and Hydrocortisone) Versus Combination Chemotherapy (Docetaxel and Estramustine) in Asymptomatic Patients With Prostate Cancer and a Rising Prostate-Specific Antigen After Androgen Suppression

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				ECOG-E1899 SWOG-E1899, CALGB-E1899, E1899, NCT00027859

Last Modified: 1/25/2008 First Published: 2/1/2002


8.		Phase III Randomized Study of Androgen Blockade With Concurrent Chemotherapy Versus Delayed Chemotherapy in Patients With High-Risk Hormone-Naive Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				RTOG-P-0014 RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654

Last Modified: 6/12/2007


9.		Phase III Radiotherapy Followed by Estracyt or CTX for Stage B/C/D Prostatic Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NPCTG-1000


10.		Phase III DES or Orchiectomy vs CTX/5-FU plus DES or Orchiectomy vs Estracyt for Stage D2 Prostate Cancer without Prior Endocrine Therapy or Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NPCTG-1300

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute